Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microglia | 23 | 2024 | 152 | 5.580 |
Why?
|
| Chemokine CX3CL1 | 9 | 2024 | 13 | 3.270 |
Why?
|
| Receptors, Chemokine | 16 | 2016 | 68 | 2.990 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2023 | 87 | 2.170 |
Why?
|
| Retina | 6 | 2024 | 255 | 1.930 |
Why?
|
| Inflammation | 9 | 2024 | 577 | 1.890 |
Why?
|
| Mice | 36 | 2024 | 5668 | 1.440 |
Why?
|
| Central Nervous System | 8 | 2016 | 130 | 1.340 |
Why?
|
| Neurocysticercosis | 5 | 2016 | 27 | 1.290 |
Why?
|
| Chemokines | 5 | 2016 | 89 | 1.230 |
Why?
|
| Animals | 43 | 2024 | 14307 | 1.170 |
Why?
|
| Myeloid Cells | 4 | 2013 | 28 | 1.070 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 4 | 2016 | 53 | 1.020 |
Why?
|
| Brain | 10 | 2016 | 1268 | 1.010 |
Why?
|
| Demyelinating Diseases | 2 | 2022 | 15 | 0.990 |
Why?
|
| Mice, Inbred C57BL | 19 | 2023 | 1530 | 0.930 |
Why?
|
| Diabetic Retinopathy | 1 | 2024 | 65 | 0.910 |
Why?
|
| Ancrod | 1 | 2022 | 2 | 0.860 |
Why?
|
| Diabetes Mellitus | 2 | 2024 | 465 | 0.830 |
Why?
|
| Cell Separation | 3 | 2014 | 91 | 0.770 |
Why?
|
| Chemotaxis | 2 | 2013 | 57 | 0.760 |
Why?
|
| Interleukin-1beta | 2 | 2017 | 66 | 0.730 |
Why?
|
| Fibrinogen | 4 | 2023 | 23 | 0.710 |
Why?
|
| Flow Cytometry | 8 | 2015 | 392 | 0.680 |
Why?
|
| Mice, Transgenic | 12 | 2022 | 608 | 0.670 |
Why?
|
| Leukocytes | 3 | 2018 | 68 | 0.670 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 3 | 2003 | 15 | 0.630 |
Why?
|
| Central Nervous System Diseases | 2 | 2017 | 27 | 0.620 |
Why?
|
| Eosinophilia | 1 | 2016 | 16 | 0.580 |
Why?
|
| Leukocytes, Mononuclear | 5 | 2015 | 224 | 0.540 |
Why?
|
| Signal Transduction | 5 | 2024 | 1802 | 0.540 |
Why?
|
| Receptors, CCR2 | 3 | 2011 | 26 | 0.530 |
Why?
|
| Green Fluorescent Proteins | 3 | 2015 | 200 | 0.530 |
Why?
|
| Spinal Cord | 3 | 2013 | 85 | 0.520 |
Why?
|
| Neurons | 7 | 2018 | 1130 | 0.510 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2014 | 1 | 0.500 |
Why?
|
| Disease Models, Animal | 11 | 2023 | 1300 | 0.490 |
Why?
|
| Astrocytes | 1 | 2015 | 203 | 0.480 |
Why?
|
| Receptors, HIV | 1 | 2013 | 5 | 0.470 |
Why?
|
| Receptors, Cytokine | 1 | 2013 | 11 | 0.470 |
Why?
|
| Autoimmunity | 2 | 2013 | 52 | 0.470 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 528 | 0.460 |
Why?
|
| Mice, Knockout | 8 | 2021 | 897 | 0.430 |
Why?
|
| T-Lymphocytes | 4 | 2016 | 341 | 0.410 |
Why?
|
| Neurogenesis | 3 | 2018 | 55 | 0.410 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 120 | 0.410 |
Why?
|
| Embryonic Development | 1 | 2011 | 73 | 0.400 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 152 | 0.400 |
Why?
|
| Mesocestoides | 4 | 2013 | 23 | 0.400 |
Why?
|
| Malaria, Cerebral | 2 | 2023 | 31 | 0.400 |
Why?
|
| Tauopathies | 3 | 2018 | 18 | 0.400 |
Why?
|
| Cytokines | 8 | 2023 | 569 | 0.400 |
Why?
|
| Cytological Techniques | 1 | 2011 | 14 | 0.390 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2002 | 84 | 0.380 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 283 | 0.360 |
Why?
|
| Nervous System Diseases | 2 | 2007 | 66 | 0.350 |
Why?
|
| Lateral Ventricles | 2 | 2021 | 8 | 0.330 |
Why?
|
| Humans | 16 | 2024 | 34853 | 0.310 |
Why?
|
| Membrane Glycoproteins | 2 | 2022 | 197 | 0.300 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2006 | 32 | 0.280 |
Why?
|
| Oligodendroglia | 2 | 2021 | 20 | 0.280 |
Why?
|
| Cells, Cultured | 7 | 2021 | 1442 | 0.270 |
Why?
|
| Stem Cell Niche | 2 | 2016 | 9 | 0.270 |
Why?
|
| Organ Specificity | 2 | 2018 | 123 | 0.260 |
Why?
|
| Receptors, Immunologic | 2 | 2022 | 59 | 0.250 |
Why?
|
| tau Proteins | 3 | 2018 | 161 | 0.250 |
Why?
|
| RNA | 1 | 2006 | 234 | 0.240 |
Why?
|
| Immunologic Factors | 1 | 2024 | 44 | 0.240 |
Why?
|
| Protein Isoforms | 1 | 2024 | 121 | 0.240 |
Why?
|
| Diabetes Complications | 1 | 2024 | 91 | 0.230 |
Why?
|
| Killer Cells, Natural | 2 | 2016 | 86 | 0.230 |
Why?
|
| Gene Expression Regulation | 4 | 2018 | 968 | 0.230 |
Why?
|
| Bone Marrow Cells | 2 | 2013 | 75 | 0.230 |
Why?
|
| Chemokines, CC | 1 | 2003 | 50 | 0.220 |
Why?
|
| Mice, Inbred BALB C | 4 | 2016 | 649 | 0.220 |
Why?
|
| Cuprizone | 1 | 2022 | 5 | 0.220 |
Why?
|
| Myelin Sheath | 1 | 2022 | 42 | 0.210 |
Why?
|
| Homeostasis | 2 | 2014 | 172 | 0.210 |
Why?
|
| Peptide Fragments | 2 | 2013 | 298 | 0.200 |
Why?
|
| Carrier Proteins | 1 | 2023 | 287 | 0.200 |
Why?
|
| Cell Movement | 6 | 2018 | 545 | 0.190 |
Why?
|
| Chemokine CCL2 | 3 | 2008 | 82 | 0.190 |
Why?
|
| Ligands | 2 | 2013 | 317 | 0.180 |
Why?
|
| Chromatin | 2 | 2018 | 164 | 0.180 |
Why?
|
| Immunohistochemistry | 3 | 2014 | 859 | 0.170 |
Why?
|
| Vasculitis, Central Nervous System | 1 | 2018 | 1 | 0.170 |
Why?
|
| Gliosis | 1 | 2018 | 22 | 0.170 |
Why?
|
| Integrases | 1 | 2018 | 27 | 0.160 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 46 | 0.160 |
Why?
|
| Lymphocyte Activation | 3 | 2013 | 222 | 0.160 |
Why?
|
| Female | 8 | 2016 | 19873 | 0.150 |
Why?
|
| Dendritic Cells | 3 | 2013 | 112 | 0.150 |
Why?
|
| Histones | 2 | 2018 | 177 | 0.150 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 485 | 0.140 |
Why?
|
| Mast Cells | 1 | 2016 | 77 | 0.140 |
Why?
|
| Nitrites | 1 | 2015 | 38 | 0.140 |
Why?
|
| Neuroimmunomodulation | 1 | 2015 | 13 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2018 | 325 | 0.140 |
Why?
|
| Neutrophils | 1 | 2016 | 124 | 0.140 |
Why?
|
| Alzheimer Disease | 2 | 2013 | 881 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 157 | 0.130 |
Why?
|
| Memory Disorders | 1 | 2015 | 65 | 0.130 |
Why?
|
| Adult Stem Cells | 1 | 2014 | 12 | 0.130 |
Why?
|
| Lipopolysaccharides | 3 | 2018 | 200 | 0.120 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2013 | 12 | 0.120 |
Why?
|
| Brain Injuries | 1 | 2015 | 104 | 0.120 |
Why?
|
| Antigens | 1 | 2013 | 56 | 0.120 |
Why?
|
| Immunity | 1 | 2014 | 51 | 0.120 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2013 | 3 | 0.120 |
Why?
|
| Antigens, Ly | 1 | 2013 | 7 | 0.120 |
Why?
|
| Chimera | 1 | 2013 | 15 | 0.120 |
Why?
|
| Lymphoid Tissue | 1 | 2013 | 17 | 0.120 |
Why?
|
| Interleukin-1 | 1 | 2013 | 33 | 0.120 |
Why?
|
| Adaptive Immunity | 1 | 2013 | 27 | 0.120 |
Why?
|
| Nitric Oxide | 1 | 2015 | 287 | 0.120 |
Why?
|
| Analysis of Variance | 3 | 2015 | 528 | 0.120 |
Why?
|
| Granulocyte Precursor Cells | 1 | 2013 | 2 | 0.120 |
Why?
|
| Interleukin-17 | 1 | 2013 | 54 | 0.110 |
Why?
|
| Mannose-Binding Lectins | 1 | 2013 | 14 | 0.110 |
Why?
|
| Aging | 1 | 2018 | 639 | 0.110 |
Why?
|
| Lectins, C-Type | 1 | 2013 | 35 | 0.110 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 78 | 0.110 |
Why?
|
| Microfilament Proteins | 2 | 2018 | 64 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 2 | 2018 | 72 | 0.110 |
Why?
|
| Receptors, Cell Surface | 1 | 2013 | 135 | 0.110 |
Why?
|
| Interferon-gamma | 1 | 2013 | 235 | 0.110 |
Why?
|
| Cell Cycle | 1 | 2013 | 309 | 0.110 |
Why?
|
| Macrophage Activation | 2 | 2015 | 52 | 0.110 |
Why?
|
| Blood-Brain Barrier | 3 | 2008 | 153 | 0.100 |
Why?
|
| Genes, T-Cell Receptor delta | 2 | 2002 | 5 | 0.100 |
Why?
|
| Lymphocyte Subsets | 1 | 2011 | 19 | 0.100 |
Why?
|
| Phagocytes | 1 | 2010 | 5 | 0.100 |
Why?
|
| Maze Learning | 3 | 2018 | 100 | 0.100 |
Why?
|
| Th1 Cells | 2 | 2002 | 87 | 0.100 |
Why?
|
| Cell Proliferation | 2 | 2013 | 1149 | 0.100 |
Why?
|
| Gene Expression | 2 | 2021 | 639 | 0.090 |
Why?
|
| Cell Lineage | 1 | 2010 | 88 | 0.090 |
Why?
|
| Microscopy, Confocal | 3 | 2021 | 210 | 0.090 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2010 | 95 | 0.090 |
Why?
|
| Male | 5 | 2015 | 18870 | 0.090 |
Why?
|
| Stem Cells | 1 | 2010 | 132 | 0.090 |
Why?
|
| Adoptive Transfer | 2 | 2013 | 48 | 0.090 |
Why?
|
| Chemokine CXCL2 | 1 | 2008 | 9 | 0.080 |
Why?
|
| Chemokine CXCL1 | 1 | 2008 | 15 | 0.080 |
Why?
|
| Chemokine CXCL10 | 1 | 2008 | 37 | 0.080 |
Why?
|
| Brain Chemistry | 1 | 2008 | 134 | 0.080 |
Why?
|
| Neuritis, Autoimmune, Experimental | 1 | 2007 | 1 | 0.080 |
Why?
|
| Chemokines, CX3C | 1 | 2007 | 1 | 0.080 |
Why?
|
| Chemotactic Factors | 1 | 2007 | 7 | 0.080 |
Why?
|
| Nervous System | 1 | 2007 | 29 | 0.070 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2006 | 21 | 0.070 |
Why?
|
| Motor Neuron Disease | 1 | 2006 | 4 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2021 | 562 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2006 | 55 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 608 | 0.070 |
Why?
|
| Cell Death | 1 | 2006 | 260 | 0.070 |
Why?
|
| Parkinson Disease | 1 | 2006 | 167 | 0.060 |
Why?
|
| Monocytes | 1 | 2007 | 258 | 0.060 |
Why?
|
| Fibrin | 1 | 2023 | 8 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2006 | 338 | 0.060 |
Why?
|
| Chemokine CCL3 | 1 | 2003 | 13 | 0.060 |
Why?
|
| Chemokine CCL4 | 1 | 2003 | 18 | 0.060 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2003 | 14 | 0.060 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2018 | 63 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2007 | 486 | 0.060 |
Why?
|
| Leukopenia | 1 | 2002 | 9 | 0.060 |
Why?
|
| Leishmaniasis, Visceral | 1 | 2001 | 7 | 0.050 |
Why?
|
| Leishmania donovani | 1 | 2001 | 16 | 0.050 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2021 | 10 | 0.050 |
Why?
|
| Spleen | 1 | 2001 | 192 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2002 | 420 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2015 | 878 | 0.050 |
Why?
|
| Genes, T-Cell Receptor gamma | 1 | 1999 | 3 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 1999 | 46 | 0.040 |
Why?
|
| Antigens, Differentiation | 1 | 2018 | 24 | 0.040 |
Why?
|
| Plasmodium chabaudi | 1 | 2018 | 1 | 0.040 |
Why?
|
| Time Factors | 2 | 2015 | 1681 | 0.040 |
Why?
|
| Ammonia | 1 | 2018 | 17 | 0.040 |
Why?
|
| Larva | 1 | 1999 | 117 | 0.040 |
Why?
|
| Heparin | 1 | 2018 | 34 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2018 | 32 | 0.040 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2018 | 25 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2018 | 69 | 0.040 |
Why?
|
| Antibodies | 1 | 2018 | 135 | 0.040 |
Why?
|
| S Phase | 1 | 2018 | 36 | 0.040 |
Why?
|
| Methylation | 1 | 2018 | 102 | 0.040 |
Why?
|
| Lysine | 1 | 2018 | 104 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2018 | 97 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 2018 | 233 | 0.040 |
Why?
|
| Psychomotor Disorders | 1 | 2015 | 7 | 0.030 |
Why?
|
| Rotarod Performance Test | 1 | 2015 | 13 | 0.030 |
Why?
|
| Fluoresceins | 1 | 2015 | 27 | 0.030 |
Why?
|
| Liver | 1 | 2018 | 447 | 0.030 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2015 | 14 | 0.030 |
Why?
|
| Exploratory Behavior | 1 | 2015 | 72 | 0.030 |
Why?
|
| Papio anubis | 1 | 2014 | 5 | 0.030 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2013 | 9 | 0.030 |
Why?
|
| Freund's Adjuvant | 1 | 2013 | 14 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2013 | 34 | 0.030 |
Why?
|
| Temporal Lobe | 1 | 2013 | 22 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2014 | 118 | 0.030 |
Why?
|
| Mutation | 1 | 2018 | 1023 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 2013 | 58 | 0.030 |
Why?
|
| Pertussis Toxin | 1 | 2013 | 27 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2013 | 117 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 164 | 0.030 |
Why?
|
| Frontal Lobe | 1 | 2013 | 49 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2013 | 54 | 0.030 |
Why?
|
| Immunization | 1 | 2013 | 90 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 89 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2013 | 103 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 198 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2013 | 322 | 0.030 |
Why?
|
| Hippocampus | 1 | 2015 | 546 | 0.030 |
Why?
|
| Silver Staining | 1 | 2010 | 7 | 0.020 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2010 | 7 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2010 | 44 | 0.020 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2010 | 21 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 106 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2010 | 74 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2010 | 96 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2010 | 64 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 93 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 129 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2010 | 58 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2010 | 116 | 0.020 |
Why?
|
| Imidazoles | 1 | 2010 | 124 | 0.020 |
Why?
|
| Pyridines | 1 | 2010 | 113 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2010 | 323 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 605 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 396 | 0.020 |
Why?
|
| Phenotype | 1 | 2011 | 650 | 0.020 |
Why?
|
| Models, Biological | 1 | 2010 | 642 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2005 | 7 | 0.020 |
Why?
|
| Myelin Proteins | 1 | 2005 | 26 | 0.020 |
Why?
|
| Neurofilament Proteins | 1 | 2005 | 27 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2005 | 48 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2005 | 232 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2005 | 274 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 484 | 0.010 |
Why?
|
| Mesocricetus | 1 | 2001 | 53 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2001 | 68 | 0.010 |
Why?
|
| Cricetinae | 1 | 2001 | 217 | 0.010 |
Why?
|
| Macrophages | 1 | 2001 | 431 | 0.010 |
Why?
|